Navigation Links
S*BIO and Tragara Announce an Exclusive Worldwide License Agreement for Novel Multi-kinase Inhibitor SB1317
Date:1/20/2009

Tragara Pharmaceuticals, Inc. is a privately-held pharmaceutical company based in San Diego, Calif. The company is focused on the clinical and commercial development of proprietary medicines for the treatment of cancer and inflammation. Tragara strives to provide much-needed therapies that will contribute to patient health through better survival and an increase in the quality of life. Tragara's lead program, Capoxigem(R) (apricoxib, TG01), is currently in Phase II clinical development in lung, breast and pancreatic cancers and has completed a Phase II study in inflammation/pain. A second program, an oral multi-kinase inhibitor, TG02 (SB1317), is in late stage preclinical development.

Tragara is managed by a team of entrepreneurs with both Big Pharma and Biotech experience in the development and commercialization of oncology therapeutics. Its investors include: Domain Associates, Mitsubishi International Corporation, Morganthaler Ventures, Oxford BioScience Partners and ProQuest Investments. More information about Tragara can be found at www.tragarapharma.com.

About S*BIO Pte Ltd

S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, also entered the clinic in 2008 and has received orphan drug designation from the U.S. FDA. S*BIO has entered into a development collaboration, and option & license agreement with Onyx Pharmaceuticals, Inc. to develop and commercialize SB1518 and its other novel JAK2 inhibitor, SB1578. S*BIO's SB1317, a novel multi-kinase inhibitor, is in pre-clinical development and under a worldwide exclusive license with Tragara Pharmac
'/>"/>

SOURCE S*BIO Pte Ltd
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. S*BIO Receives Orphan Drug Designation for JAK2 Inhibitor SB1518 for the Treatment of Myeloproliferative Disorders
2. S*BIO Completes US$26 Million Equity Financing
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
5. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
6. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
7. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
8. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)... Top Gene Synthesis Companies Form International G... Practices in Risk Reduction ,Five Member Compan...is Capacity , (PRWEB) Nov...g gene synthesis companies today announced agreeme...l to promote biosecurity in the gene synthesis ind...
(Date:11/19/2009)...a, November 19 AFFiRiS AG will foc...candidate at an unexpectedly early,stage of develo...ter into,Phase II clinical trial early in 2010. Th... completion of two Phase I trials with the candida...sion on the first interim,analysis of the secondar...
(Date:11/18/2009)...tute of Standards and Technology (NIST) has demons... detecting and measuring elusive hazards such as c... in food or pesticides distributed in soil by wind...than conventional techniques for detecting traces ...cules, having distinct electrically positive and n...
(Date:11/18/2009)...lka-dotted postage stamp that can sniff out poison...rs. , As reported in the Sept. 13 issue of the j... team at the University of Illinois have developed...oxic industrial chemicals (TICs) that is simple, f...s. This sensor array could be useful in detecting...
Breaking Biology Technology:World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3Prototype NIST method detects and measures elusive hazards 2Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3
...ing a net loss in 2007, Hutchinson Technology , a... has announced 165 layoffs at its Eau Claire manuf...pewa Herald . , ,Job losses at the Eau Claire plan...0 employees, which also affects plants in Hutchins...company is headquartered in Hutchinson, Minn. , ,W...
...first in a four-part series of articles regarding ...awsuit and, in particular, the discovery of electr...torney Tim Hansen of the law firm Michael Best an...e subsequent articles will explain specific provis...l Rules of Civil Procedure (Rules) were amended co...
... was founded in 1998, EMSystem has grown to beco...b-based communications and resource management for...t the Milwaukee-based company might never have att... had it not been for corporate venturing . EMSyst... those ventures that required the support and nurt...
Other Biology Technology:Quick peeks, Clawback Agreements, and the rules of electronic discovery 2Quick peeks, Clawback Agreements, and the rules of electronic discovery 3Pre-eminent, web-based companies owe success to corporate venturing 2Pre-eminent, web-based companies owe success to corporate venturing 3Pre-eminent, web-based companies owe success to corporate venturing 4Pre-eminent, web-based companies owe success to corporate venturing 5Pre-eminent, web-based companies owe success to corporate venturing 6
(Date:11/20/2009)... work on many scientific and technological frontie...rovided support that totals nearly $4.3 million fo...rs under the American Recovery and Reinvestment Ac...d grants for investigation of solar phenomena. Phi...will enhance the capabilities of NJIT,s Big Bear S...
(Date:11/20/2009)...University of Oklahoma researchers were sequencing...enome project. Today, the OU Advanced Center for...onal effort to sequence the tomato genome with a $...Foundation for plant genomics. , "The tomato ha...the tomato and crop yields will improve quality of...
(Date:11/20/2009)...ember 19, 2009 The estimated 4.6 million American...f developing respiratory symptoms due to poor air ...re study undertaken earlier this year by investiga...rinary Medicine. , The studywhich polled more th...percent of individuals working in barns complained...
Breaking Biology News(10 mins):NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2NSF awards $7.5M grant to University of Oklahoma for plant genomics 2Barn personnel experience higher-than-average rates of respiratory symptoms 2The bitter side of sweeteners 8874 1The bitter side of sweeteners 8874 2Campbell Alliance Adds Industry Veterans Jon W McGarity and David Lilley as Executive Vice Presidents 12673 1Campbell Alliance Adds Industry Veterans Jon W McGarity and David Lilley as Executive Vice Presidents 12673 2Campbell Alliance Adds Industry Veterans Jon W McGarity and David Lilley as Executive Vice Presidents 12673 3Campbell Alliance Adds Industry Veterans Jon W McGarity and David Lilley as Executive Vice Presidents 12673 4Campbell Alliance Adds Industry Veterans Jon W McGarity and David Lilley as Executive Vice Presidents 12673 5Campbell Alliance Adds Industry Veterans Jon W McGarity and David Lilley as Executive Vice Presidents 12673 6AMICAS Set to Join Russell 3000 Index 49217 1AMICAS Set to Join Russell 3000 Index 49217 2AMICAS Set to Join Russell 3000 Index 49217 3
...been associated with altered amounts of slow wave ...ograph (EEG) activity and impaired sleep regulatio...journal SLEEP finds that CFS is also associated wi...sleep challenge, suggesting an impairment of the b...tudy, authored by Roseanna Armitage, PhD, and coll...
...es every year. And, according to the national Cent...rcent of the U.S. population on average will come ...among health experts, a bigger concern than the se...human strain of avian flu. And officials say it is...me but when. Are we prepared? In a word, say three...
...vent the immune system from launching an all-out f...ntity of a nutrient "floodgate" that serves to pro... Their findings appear in the May 4, 2007 issue of...The researchers found that animals lacking a prote...cute inflammation in deep pockets of visceral fat....
Other Biology News:US control strategies may make flu epidemics worse, UCLA study shows 2Keeping the immune system from starting a 'food fight' 2
...ion: Topoisomerase I relaxes both positively and n...and rejoining of phosphodiester bonds (1,2) . Rela...olecules to be differentiated by a single nucleoti... I is active in the absence of Mn 2+ and can be u...
Mycoplasma Testing from AbD Serotec
...nt is a genetically engineered Klenow polymerase i...emoved, leaving only the 5 to 3 polymerase activit...xo- Klenow Fragment the enzyme of choice for isoto... primed method, and for DNA sequencing by the Sang...
T4 RNA Ligase from Roche Applied Science
Biology Products: